Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

PURSUIT: Um Programa Escolar Tecnologicamente Aprimorado para Melhorar o Enfrentamento Infantil e Prevenir o Uso de Substâncias.

5 de outubro de 2026 atualizado por: Natoshia Cunningham, Michigan State University

PURSUIT: Um Programa Escolar Tecnologicamente Aumentado para Melhorar o Enfrentamento Infantil e Prevenir o Consumo de Substâncias.

The study investigators aim to test an online support platform for Michigan youth aged 8-18 years enrolled in elementary, middle, or high school and their parent/caregiver. The online support platform will be hosted on the Computerized Intervention Authoring System (CIAS) 3.0 and will provide evidence-based cognitive behavioral coping skills for physical (pain) and mental (stress, mood) health symptoms, with additional substance use prevention content for youth aged 12 and older. Evaluations will occur at baseline and then a post assessment approximately 8 weeks later.

Visão geral do estudo

Descrição detalhada

The study investigator's aims are to:

  1. Evaluate the feasibility and acceptability of the PURSUIT online support platform using mixed methods.
  2. Explore the impact of PURSUIT on youth's physical (pain) and mental health (stress, anxiety, mood, perceived risk of substance use) symptoms at post assessment.

Consented youth will complete a baseline assessment (week 1), and then will use the PURSUIT online platform (expected duration is 6 week), and complete a post assessment (week 8).

Within the PURSUIT platform, all youth will have access to tools teaching cognitive-behavioral strategies for managing mood, anxiety, stress, and physical pain. Youth aged 12 and older will have access to additional content presenting cognitive-behavioral strategies for reducing the risk of substance use.

Youth will provide data on their symptoms (e.g thoughts, mood, behaviors, sleep, pain, and stress) at baseline and post assessment. A caregiver will report on the child's demographics, adverse childhood experience (ACE) exposure, school performance/attendance and their own mood. At post-assessment, the youth will also be asked to take part in a brief, semi-structured interview regarding their experiences with PURSUIT.

Tipo de estudo

Intervencional

Inscrição (Estimado)

100

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Natoshia R Cunningham, PhD
  • Número de telefone: 845-662-6198
  • E-mail: natoshia@msu.edu

Estude backup de contato

Locais de estudo

    • Michigan
      • Grand Rapids, Michigan, Estados Unidos, 49503
        • Michigan State University

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

8 anos a 18 anos (Filho, Adulto)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Aged eight to 18 years
  • Enrolled in a Michigan elementary, middle, or high school

Exclusion Criteria:

  • Age under 8
  • Age over 18 years
  • Non-enrollment in A Michigan school.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: PURSUIT Self-Management Portal

All youth enrolled in the study will have access to an online self-management platform, hosted by the Computerized Intervention Authoring System (CIAS). The self-management platform comprises evidence-based cognitive-behavioral psycho-education and skills broadly applicable to physical (pain) and mental (stress, mood) health symptoms. Youth aged twelve and older will have access to content related to preventing substance use. Materials include instructional videos, handouts, and worksheets.

PURSUIT is an online self-management platform for youth aged 8-18 and one caregiver that provides cognitive-behavioral coping skills for physical and mental health symptoms, plus substance use prevention content for youth aged 12 and older.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
PURSUIT Feasibility-Youth Retention
Prazo: From baseline to post assessment, approximately 8 weeks

The percentage of youth who complete a post-assessment measure, relative to those who complete a baseline assessment.

From baseline to post assessment, approximately 8 weeks
PURSUIT Feasibility/Acceptability
Prazo: From baseline to post-assessment, approximately 8 weeks.

Youth will complete a brief, semi-structured interview following a six-week period of engagement with the online self-management portal to assess the feasibility ("Do you think you will be able to integrate these skills into your schedule with school/work?") and acceptability of PURSUIT.

From baseline to post-assessment, approximately 8 weeks.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Changes in pain, as measured by the Pain Visual Analog Scale (VAS)
Prazo: From baseline to post-assessment, approximately 8 weeks.

Youth will report their average pain intensity over the past two weeks using a Visual Analog Scale (VAS). Responses range from 0 (no pain) to 10 (worst imaginable pain), with ratings ≥ 3 indicating moderate pain.

From baseline to post-assessment, approximately 8 weeks.
Change in functional disability, measured using the Functional Disability Inventory (FDI)
Prazo: From baseline to post-assessment, approximately 8 weeks.

The 15-item FDI assesses youths' difficulty performing tasks across home, school, recreational, and social settings over the "past few days" due to physical symptoms. Items are rated from 0 ("no trouble") to 4 ("impossible") and summed, yielding total scores of 0-60 with scores ≥7 suggesting greater than minimal disability

From baseline to post-assessment, approximately 8 weeks.
Changes in post-traumatic stress disorder symptoms (PTSD), measured using the UCLA Reaction Index for DSM-5 Brief Screening Form
Prazo: From baseline to post-assessment, approximately 8 weeks.

The UCLA Reaction Index for DSM-5 Brief Screening Form is an 11-item measure of how often youth experienced psychological stress and physiological reactivity due to internal or external trauma reminders, intrusive trauma-related memories, avoidance of internal and external reminders of trauma, emotional dysregulation, attention issues, feelings of detachment, and sleep disturbance over the past month. Items are scored from zero (none of the time) to four (most of the time) and summed; scores of 11-20 suggest mild PTSD symptoms, while scores ≥21 are indicative of potential PTSD. We adapted this measure to not query the type of traumatic exposure experienced by youth. It will only be completed by those who endorse exposure (yes/no) to a frightening or upsetting event.

From baseline to post-assessment, approximately 8 weeks.
Change in anxiety symptoms, measured using the Screen for Child Anxiety Related Disorders (SCARED)
Prazo: From baseline to post-assessment, approximately 8 weeks.

The 41-item Screen for Child Anxiety Related Disorders (SCARED) assesses past 3-month anxiety symptoms. Items are scored on a 3-point Likert-style scale (0 = not true or hardly ever true, 2=very true or often true), and summed to yield total scores of 0-82 with higher scores indicating greater anxiety and scores ≥25 suggesting clinical significance.

From baseline to post-assessment, approximately 8 weeks.
Change in depressive symptoms, measured using the PROMIS Pediatric Short Form 8a
Prazo: From baseline to post-assessment, approximately 8 weeks.

Youth will report the frequency (1=never, 5=almost always) of past-week depressive symptoms (e.g., sadness, loneliness) using the eight-item PROMIS Pediatric Depressive Symptoms Short Form 8a. Raw summed scores (range 8 to 40) are converted to T-scores (mean 50, standard deviation 10), with T-scores >55 suggesting mild or higher symptoms.

From baseline to post-assessment, approximately 8 weeks.
Change in fatigue symptoms; as measured by the PROMIS Pediatric Short Form 10a
Prazo: From baseline to post-assessment, approximately 8 weeks.

Past week fatigue symptoms will be self-reported by youth using the 10-item PROMIS Pediatric Short Form. Items ("Being tired made it hard for me to play or go out with my friends as much as I'd like") are rated on a 5-point Likert-style scale (1=never, 5=almost always) and summed in to total scores, which are converted into T-scores (>55 suggesting at least mild symptoms).

From baseline to post-assessment, approximately 8 weeks.
Change in sleep disturbance symptoms, measured using the PROMIS Pediatric Sleep Disturbance Short Form 8a
Prazo: From baseline to post-assessment; approximately 8 weeks

The frequency (1=never, 5=almost always) with which youth experienced sleep disturbance symptoms (e.g., trouble falling or staying asleep) in the past week will be assessed using the eight-item PROMIS Pediatric Sleep Disturbance Short Form. T-scores (>55 indicative of mild or greater symptoms) will be derived from summed raw scores.

From baseline to post-assessment; approximately 8 weeks
Change in youths' perceived risk of substance use; measured using Monitoring The Future items
Prazo: From baseline through post-assessment; approximately 8 weeks.

Youth age 12 and older will report how risky (1= No Risk, 4=Great Risk) they perceive different cigarette, cannabis, alcohol, or vaping use behaviors (e.g., occasional versus regular use) using 12 items from the 2023 Monitoring the Future (MTF) study. MTF is an ongoing longitudinal panel study conducted by the University of Michigan that includes annual surveys of nationally representative samples of 8th, 10,th and 12th grade youth.

From baseline through post-assessment; approximately 8 weeks.
Change in youth's substance use behaviors; assessed using the Screening to Brief Intervention (S2B1)
Prazo: From baseline through post-assessment; approximately 8 weeks.

The frequency (never, once or twice, monthly, weekly or more often) of past-year nicotine, alcohol, cannabis, and other substance use behaviors will be assessed for youth 12 years and older using the youth-reported Screening to Brief Intervention (S2BI)

From baseline through post-assessment; approximately 8 weeks.
Changes in caregivers' depression, anxiety, and stress as measured by the Depression Anxiety and Stress Scales 21 (DASS21)
Prazo: From baseline to post-assessment, approximately 8 weeks.

The DASS21 depression, anxiety, and stress on a scale of 0-63 with 0 indicating low levels of these feelings, and 63 indicating high levels. This measure will only be completed by caregivers.

From baseline to post-assessment, approximately 8 weeks.
Change in stress, measured by the PROMIS Pediatric Psychological Stress Experiences 8a
Prazo: From baseline to post-assessment; approximately 8 weeks

Youth will report how often (1=never, 5=almost always) they experienced feelings of stress over the past week using the eight-item PROMIS Psychological Stress Experiences-Short Form 8a. As per other PROMIS short forms, summed scores are converted to T-scores.

From baseline to post-assessment; approximately 8 weeks
Patient Global Impression of Change
Prazo: post-assessment; approximately 8 weeks after baseline

A single-item measure completed by the child and caregiver that assesses perceived overall change in the child's status since completing the intervention. Scores range from 1 (Very Much Improved) to 7 (Very Much Worse).

post-assessment; approximately 8 weeks after baseline

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Youth Engagement
Prazo: From baseline to post-assessment, approximately 8 weeks

The percent of youth who complete at least one activity within the platform, relative to those who complete baseline assessments.

From baseline to post-assessment, approximately 8 weeks
Adverse Childhood Experiences (ACEs)
Prazo: Baseline

Youth's lifetime exposure to nine ACEs (e.g., violence, household dysfunction) will be reported by caregivers (if age <18) using items adapted from the National Survey of Children's Health.

Baseline
Family Demographic Information
Prazo: Baseline

Parents/caregivers will report youths' age, sex at birth, racial and ethnic identities, household income, health insurance status/type, and their own highest level of education at baseline.

Baseline
Youth School Attendance
Prazo: From baseline to post-assessment; approximately 8 weeks

Parent/caregivers will report the frequency with which their child misses or is late to school due to physical and/or mental health symptoms over the past month at baseline and after engaging with the self-management platform

From baseline to post-assessment; approximately 8 weeks
Symptom status and program motivation
Prazo: baseline

A brief intake questionnaire assessing whether participants experience pain, worries or sad feelings, and stress at baseline and their reasons for participating in the program.

baseline

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de novembro de 2026

Conclusão Primária (Estimado)

1 de março de 2027

Conclusão do estudo (Estimado)

1 de julho de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

24 de novembro de 2025

Enviado pela primeira vez que atendeu aos critérios de CQ

24 de novembro de 2025

Primeira postagem (Real)

5 de dezembro de 2025

Atualizações de registro de estudo

Última Atualização Postada (Real)

6 de outubro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

5 de outubro de 2026

Última verificação

1 de maio de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • STUDY00011346
  • G-2404-153994 (Número de outro subsídio/financiamento: Michigan Health Endowment Fund)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

We will not publicly share to protect participant identities but de-identified data may be made available upon reasonable request.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever